Literature DB >> 16397244

Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.

Dionne R Morris1, Yu Ding, Tiffany K Ricks, Anuradha Gullapalli, Breann L Wolfe, JoAnn Trejo.   

Abstract

Protease-activated receptors (PAR) are G protein-coupled receptors that function as cell-surface sensors for coagulant proteases, as well as other proteases associated with the tumor microenvironment. PAR1 is activated by thrombin whereas the upstream coagulant protease VIIa bound to tissue factor and Xa can activate both PAR1 and PAR2. PAR1 has been implicated in tumor cell growth, migration, and invasion whereas the function of PAR2 in these processes is largely unknown. Towards defining the functional importance of PAR2 in cancer cells, we used small interfering RNAs to deplete highly invasive breast cancer cells of endogenous PAR proteins. Our findings strongly suggest that PAR2 is critical for MDA-MB-231 and BT549 breast cancer cell migration and invasion towards NIH 3T3 fibroblast conditioned medium. To define the relative importance of PAR1 versus PAR2 in mediating factor VIIa and Xa responses, we assessed signaling in cancer cells lacking either endogenous PAR1 or PAR2 proteins. Strikingly, in MDA-MB-231 cells depleted of PAR2, we observed a marked inhibition of VIIa and Xa signaling to phosphoinositide hydrolysis and extracellular signal-regulated kinase 1/2 activation whereas signaling by VIIa and Xa remained intact in PAR1-deficient cells. Factor VIIa and Xa-induced cellular migration was also impaired in MDA-MB-231 cells deficient in PAR2 but not in cells lacking PAR1. Together, these studies reveal the novel findings that PAR2, a second protease-activated G protein-coupled receptor, has a critical role in breast cancer cell migration and invasion and functions as the endogenous receptor for coagulant proteases VIIa and Xa in these cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16397244     DOI: 10.1158/0008-5472.CAN-05-1735

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  79 in total

Review 1.  Protease-activated receptor 2 signaling in inflammation.

Authors:  Andrea S Rothmeier; Wolfram Ruf
Journal:  Semin Immunopathol       Date:  2011-10-06       Impact factor: 9.623

2.  Discovery of Novel Nonpeptidic PAR2 Ligands.

Authors:  Ilona Klösel; Maximilian F Schmidt; Jonas Kaindl; Harald Hübner; Dorothee Weikert; Peter Gmeiner
Journal:  ACS Med Chem Lett       Date:  2020-05-22       Impact factor: 4.345

Review 3.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

Review 4.  Beta-arrestins and heterotrimeric G-proteins: collaborators and competitors in signal transduction.

Authors:  K Defea
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

5.  Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer.

Authors:  Mohammad Jaber; Miriam Maoz; Arun Kancharla; Daniel Agranovich; Tamar Peretz; Sorina Grisaru-Granovsky; Beatrice Uziely; Rachel Bar-Shavit
Journal:  Cell Mol Life Sci       Date:  2013-11-01       Impact factor: 9.261

Review 6.  Breast cancer phenotypes regulated by tissue factor-factor VII pathway: Possible therapeutic targets.

Authors:  Shiro Koizume; Yohei Miyagi
Journal:  World J Clin Oncol       Date:  2014-12-10

7.  Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells.

Authors:  T Albrektsen; B B Sørensen; G M Hjortø; J Fleckner; L V M Rao; L C Petersen
Journal:  J Thromb Haemost       Date:  2007-04-27       Impact factor: 5.824

8.  Factor Xa stimulates proinflammatory and profibrotic responses in fibroblasts via protease-activated receptor-2 activation.

Authors:  Keren Borensztajn; Jurriën Stiekema; Sebastiaan Nijmeijer; Pieter H Reitsma; Maikel P Peppelenbosch; C Arnold Spek
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

9.  Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease.

Authors:  J E Bluff; S R Menakuru; S S Cross; S E Higham; S P Balasubramanian; N J Brown; M W Reed; C A Staton
Journal:  Br J Cancer       Date:  2009-07-21       Impact factor: 7.640

10.  PAR1 is selectively over expressed in high grade breast cancer patients: a cohort study.

Authors:  Norma A Hernández; Elma Correa; Esther P Avila; Teresa A Vela; Víctor M Pérez
Journal:  J Transl Med       Date:  2009-06-18       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.